{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:21:02Z","timestamp":1794543662099,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770747"],"award-info":[{"award-number":["81770747"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970646"],"award-info":[{"award-number":["81970646"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Renal fibrosis is the common feature of all progressive kidney diseases and exerts great burden on public health worldwide. The maladaptive repair mechanism of tubular epithelial cells, an important mediator of renal fibrogenesis, manifests with partial epithelial\u2013mesenchymal transition (EMT) and cell cycle arrest. The aim of this study is to investigate the possible correlation between partial EMT and cell cycle arrest, and elucidate the underlying mechanism. We examined human kidney allograft samples with interstitial fibrosis and three mice renal fibrosis models, unilateral ureter obstruction (UUO), ischemia\u2013reperfusion injury, and Adriamycin nephropathy. The partial EMT process and p53\u2013p21 axis were elevated in both human allograft with interstitial fibrosis, as well as three mice renal fibrosis models, and showed a time-dependent increase as fibrosis progressed in the UUO model. Snai1 controlled the partial EMT process, and led to parallel changes in renal fibrosis, G2\/M arrest, and inflammation. p53\u2013p21 axis arrested cell cycle at G2\/M, and prompted partial EMT and fibrosis together with inflammation. NF-\u03baB inhibitor Bay11-7082 disrupted the reciprocal loop between Snai1-induced partial EMT and p53\u2013p21-mediated G2\/M arrest. We demonstrated the reciprocal loop between partial EMT and G2\/M arrest of TECs during renal fibrogenesis and revealed NF-\u03baB-mediated inflammatory response as the underlying mechanism. This study suggests that targeting NF-\u03baB might be a plausible therapeutic strategy to disrupt the reciprocal loop between partial EMT and G2\/M arrest, therefore alleviating renal fibrosis.<\/jats:p>","DOI":"10.1038\/s41419-020-03322-y","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T20:09:55Z","timestamp":1610050195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Snai1-induced partial epithelial\u2013mesenchymal transition orchestrates p53\u2013p21-mediated G2\/M arrest in the progression of renal fibrosis via NF-\u03baB-mediated inflammation"],"prefix":"10.1038","volume":"12","author":[{"given":"Ruochen","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiming","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"3322_CR1","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3389\/fphar.2019.00770","volume":"10","author":"SN Knoppert","year":"2019","unstructured":"Knoppert, S. N., Valentijn, F. A., Nguyen, T. Q., Goldschmeding, R. & Falke, L. L. Cellular senescence and the kidney: potential therapeutic targets and tools. Front. Pharmacol. 10, 770 (2019).","journal-title":"Front. Pharmacol."},{"key":"3322_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","volume":"80","author":"BD Humphreys","year":"2018","unstructured":"Humphreys, B. D. Mechanisms of renal fibrosis. Annu. Rev. Physiol. 80, 309\u2013326 (2018).","journal-title":"Annu. Rev. Physiol."},{"key":"3322_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrneph.2015.215","volume":"12","author":"D Zhou","year":"2016","unstructured":"Zhou, D. & Liu, Y. Renal fibrosis in 2015: understanding the mechanisms of kidney fibrosis. Nat. Rev. Nephrol. 12, 68\u201370 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"3322_CR4","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/s41419-018-1157-x","volume":"9","author":"R Qi","year":"2018","unstructured":"Qi, R. & Yang, C. Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury. Cell Death Dis. 9, 1126 (2018).","journal-title":"Cell Death Dis."},{"key":"3322_CR5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.kint.2017.09.033","volume":"93","author":"BC Liu","year":"2018","unstructured":"Liu, B. C., Tang, T. T., Lv, L. L. & Lan, H. Y. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 93, 568\u2013579 (2018).","journal-title":"Kidney Int."},{"key":"3322_CR6","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri, R. & Neilson, E. G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Investig. 112, 1776\u20131784 (2003).","journal-title":"J. Clin. Investig."},{"key":"3322_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1172\/JCI0215518","volume":"110","author":"M Iwano","year":"2002","unstructured":"Iwano, M. et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Investig. 110, 341\u2013350 (2002).","journal-title":"J. Clin. Investig."},{"key":"3322_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.diff.2016.05.008","volume":"92","author":"YB Sun","year":"2016","unstructured":"Sun, Y. B., Qu, X., Caruana, G. & Li, J. The origin of renal fibroblasts\/myofibroblasts and the signals that trigger fibrosis. Differentiation 92, 102\u2013107 (2016).","journal-title":"Differentiation"},{"key":"3322_CR9","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/nm.3901","volume":"21","author":"MT Grande","year":"2015","unstructured":"Grande, M. T. et al. Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat. Med. 21, 989\u2013997 (2015).","journal-title":"Nat. Med."},{"key":"3322_CR10","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm.3902","volume":"21","author":"S Lovisa","year":"2015","unstructured":"Lovisa, S. et al. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat. Med. 21, 998\u20131009 (2015).","journal-title":"Nat. Med."},{"key":"3322_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00204-014-1249-z","volume":"89","author":"V Romanov","year":"2015","unstructured":"Romanov, V., Whyard, T., Waltzer, W., Grollman, A. & Rosenquist, T. Aristolochic acid-induced apoptosis and G2 cell cycle arrest depends on ROS generation and MAP kinases activation. Arch. Toxicol. 89, 47\u201356 (2015).","journal-title":"Arch. Toxicol."},{"key":"3322_CR12","doi-asserted-by":"publisher","first-page":"F1140","DOI":"10.1152\/ajprenal.00262.2004","volume":"287","author":"M Jiang","year":"2004","unstructured":"Jiang, M., Yi, X., Hsu, S., Wang, C. Y. & Dong, Z. Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity. Am. J. Physiol. Ren. Physiol. 287, F1140\u2013F1147 (2004).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"3322_CR13","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.kint.2019.06.021","volume":"96","author":"H Shimoda","year":"2019","unstructured":"Shimoda, H. et al. Inhibition of the H3K4 methyltransferase MLL1\/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16(INK4a). Kidney Int. 96, 1162\u20131175 (2019).","journal-title":"Kidney Int."},{"key":"3322_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/01.ASN.0000040596.23073.01","volume":"14","author":"KJ Kelly","year":"2003","unstructured":"Kelly, K. J., Plotkin, Z., Vulgamott, S. L. & Dagher, P. C. P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor. J. Am. Soc. Nephrol. 14, 128\u2013138 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3322_CR15","doi-asserted-by":"crossref","unstructured":"Jin, H. et al. Epithelial innate immunity mediates tubular cell senescence after kidney injury. JCI Insight 4, e125490 (2019).","DOI":"10.1172\/jci.insight.125490"},{"key":"3322_CR16","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1681\/ASN.2017050574","volume":"29","author":"C Luo","year":"2018","unstructured":"Luo, C. et al. Wnt9a promotes renal fibrosis by accelerating cellular senescence in tubular epithelial cells. J. Am. Soc. Nephrol. 29, 1238\u20131256 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3322_CR17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1681\/ASN.2018121251","volume":"30","author":"MH Docherty","year":"2019","unstructured":"Docherty, M. H., O\u2019Sullivan, E. D., Bonventre, J. V. & Ferenbach, D. A. Cellular senescence in the kidney. J. Am. Soc. Nephrol. 30, 726\u2013736 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3322_CR18","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","volume":"102","author":"C Roufosse","year":"2018","unstructured":"Roufosse, C. et al. A 2018 reference guide to the banff classification of renal allograft pathology. Transplantation 102, 1795\u20131814 (2018).","journal-title":"Transplantation"},{"key":"3322_CR19","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1172\/JCI200319270","volume":"112","author":"M Sato","year":"2003","unstructured":"Sato, M., Muragaki, Y., Saika, S., Roberts, A. & Ooshima, A. Targeted disruption of TGF-beta1\/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Investig. 112, 1486\u20131494 (2003).","journal-title":"J. Clin. Investig."},{"key":"3322_CR20","doi-asserted-by":"publisher","first-page":"15.28.11","DOI":"10.1002\/0471142735.im1528s108","volume":"108","author":"YM Wang","year":"2015","unstructured":"Wang, Y. M., Wang, Y., Harris, D. C. H., Alexander, S. I. & Lee, V. W. S. Adriamycin nephropathy in BALB\/c mice. Curr. Protoc. Immunol. 108, 15.28.11\u201315.28.16 (2015).","journal-title":"Curr. Protoc. Immunol."},{"key":"3322_CR21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.celrep.2015.12.071","volume":"14","author":"HM Kang","year":"2016","unstructured":"Kang, H. M. et al. Sox9-positive progenitor cells play a key role in renal tubule epithelial regeneration in mice. Cell Rep. 14, 861\u2013871 (2016).","journal-title":"Cell Rep."},{"key":"3322_CR22","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1038\/sj.mt.6300314","volume":"15","author":"T Suda","year":"2007","unstructured":"Suda, T. & Liu, D. Hydrodynamic gene delivery: its principles and applications. Mol. Ther. 15, 2063\u20132069 (2007).","journal-title":"Mol. Ther."},{"key":"3322_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41419-019-1483-7","volume":"10","author":"X Peng","year":"2019","unstructured":"Peng, X. et al. ATG5-mediated autophagy suppresses NF-\u03baB signaling to limit epithelial inflammatory response to kidney injury. Cell Death Dis. 10, 253 (2019).","journal-title":"Cell Death Dis."},{"key":"3322_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10100-8","volume":"10","author":"V Prakash","year":"2019","unstructured":"Prakash, V. et al. Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease. Nat. Commun. 10, 2110 (2019).","journal-title":"Nat. Commun."},{"key":"3322_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13287-017-0760-6","volume":"9","author":"B Liu","year":"2018","unstructured":"Liu, B. et al. Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4\/NF-\u03baB signaling pathway in vivo and in vitro. Stem cell Res. Ther. 9, 7 (2018).","journal-title":"Stem cell Res. Ther."},{"key":"3322_CR26","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis. FASEB J. 34, 7295\u20137310 (2020).","DOI":"10.1096\/fj.201903254R"},{"key":"3322_CR27","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1681\/ASN.2010060616","volume":"21","author":"M Zeisberg","year":"2010","unstructured":"Zeisberg, M. & Duffield, J. S. Resolved: EMT produces fibroblasts in the kidney. J. Am. Soc. Nephrol. 21, 1247\u20131253 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3322_CR28","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-019-1897-5","volume":"577","author":"J Su","year":"2020","unstructured":"Su, J. et al. TGF-\u03b2 orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1. Nature 577, 566\u2013571 (2020).","journal-title":"Nature"},{"key":"3322_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1681\/ASN.2008121226","volume":"21","author":"Y Liu","year":"2010","unstructured":"Liu, Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J. Am. Soc. Nephrol. 21, 212\u2013222 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3322_CR30","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.7150\/thno.32352","volume":"9","author":"W Chen","year":"2019","unstructured":"Chen, W. et al. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation. Theranostics 9, 3980\u20133991 (2019).","journal-title":"Theranostics"},{"key":"3322_CR31","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1681\/ASN.2013080902","volume":"25","author":"D Zhang","year":"2014","unstructured":"Zhang, D. et al. Tubular p53 regulates multiple genes to mediate AKI. J. Am. Soc. Nephrol. 25, 2278\u20132289 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3322_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/jmcb\/mjy042","volume":"11","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. p53 upregulated by HIF-1alpha promotes hypoxia-induced G2\/M arrest and renal fibrosis in vitro and in vivo. J. Mol. Cell Biol. 11, 371\u2013382 (2019).","journal-title":"J. Mol. Cell Biol."},{"key":"3322_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nm.2144","volume":"16","author":"L Yang","year":"2010","unstructured":"Yang, L., Besschetnova, T. Y., Brooks, C. R., Shah, J. V. & Bonventre, J. V. Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury. Nat. Med. 16, 535\u2013543 (2010). 531p following 143.","journal-title":"Nat. Med."},{"key":"3322_CR34","doi-asserted-by":"publisher","first-page":"16109","DOI":"10.18632\/oncotarget.14884","volume":"8","author":"D Dong","year":"2017","unstructured":"Dong, D. et al. Alleviation of senescence and epithelial-mesenchymal transition in aging kidney by short-term caloric restriction and caloric restriction mimetics via modulation of AMPK\/mTOR signaling. Oncotarget 8, 16109\u201316121 (2017).","journal-title":"Oncotarget"},{"key":"3322_CR35","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1038\/onc.2012.640","volume":"32","author":"A Rufini","year":"2013","unstructured":"Rufini, A., Tucci, P., Celardo, I. & Melino, G. Senescence and aging: the critical roles of p53. Oncogene 32, 5129\u20135143 (2013).","journal-title":"Oncogene"},{"key":"3322_CR36","doi-asserted-by":"crossref","unstructured":"Noren Hooten, N. & Evans, M. K. Techniques to induce and quantify cellular senescence. J. Vis. Exp. 2017, 55533 (2017).","DOI":"10.3791\/55533"},{"key":"3322_CR37","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1681\/ASN.2017020190","volume":"28","author":"S Djudjaj","year":"2017","unstructured":"Djudjaj, S. et al. Macrophage migration inhibitory factor limits renal inflammation and fibrosis by counteracting tubular cell cycle arrest. J. Am. Soc. Nephrol. 28, 3590\u20133604 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3322_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pharmthera.2018.10.013","volume":"195","author":"C Tang","year":"2019","unstructured":"Tang, C. et al. P53 in kidney injury and repair: mechanism and therapeutic potentials. Pharmacol. Ther. 195, 5\u201312 (2019).","journal-title":"Pharmacol. Ther."},{"key":"3322_CR39","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/nature07986","volume":"458","author":"DR Green","year":"2009","unstructured":"Green, D. R. & Kroemer, G. Cytoplasmic functions of the tumour suppressor p53. Nature 458, 1127\u20131130 (2009).","journal-title":"Nature"},{"key":"3322_CR40","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1681\/ASN.2013121270","volume":"25","author":"Y Ying","year":"2014","unstructured":"Ying, Y., Kim, J., Westphal, S. N., Long, K. E. & Padanilam, B. J. Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury. J. Am. Soc. Nephrol. 25, 2707\u20132716 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3322_CR41","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.cellsig.2014.02.017","volume":"26","author":"J Overstreet","year":"2014","unstructured":"Overstreet, J., Samarakoon, R., Meldrum, K. & Higgins, P. Redox control of p53 in the transcriptional regulation of TGF-\u03b21 target genes through SMAD cooperativity. Cell. Signal. 26, 1427\u20131436 (2014).","journal-title":"Cell. Signal."},{"key":"3322_CR42","doi-asserted-by":"publisher","first-page":"8277","DOI":"10.7150\/thno.35686","volume":"9","author":"Q Yang","year":"2019","unstructured":"Yang, Q. et al. Conditional knockout of TGF-betaRII \/Smad2 signals protects against acute renal injury by alleviating cell necroptosis, apoptosis and inflammation. Theranostics 9, 8277\u20138293 (2019).","journal-title":"Theranostics"},{"key":"3322_CR43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.omtn.2018.07.012","volume":"12","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. lncRNA ZEB1-AS1 was suppressed by p53 for renal fibrosis in diabetic nephropathy. Mol. Ther. Nucleic Acids 12, 741\u2013750 (2018).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"3322_CR44","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.2337\/db13-0305","volume":"62","author":"S Deshpande","year":"2013","unstructured":"Deshpande, S. et al. Transforming growth factor-\u03b2-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy. Diabetes 62, 3151\u20133162 (2013).","journal-title":"Diabetes"},{"key":"3322_CR45","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng, X. M., Nikolic-Paterson, D. J. & Lan, H. Y. TGF-\u03b2: the master regulator of fibrosis. Nat. Rev. Nephrol. 12, 325\u2013338 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"3322_CR46","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ki.2010.88","volume":"77","author":"O Garcia-Sanchez","year":"2010","unstructured":"Garcia-Sanchez, O., Lopez-Hernandez, F. J. & Lopez-Novoa, J. M. An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease. Kidney Int. 77, 950\u2013955 (2010).","journal-title":"Kidney Int."},{"key":"3322_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellsig.2017.11.005","volume":"43","author":"SP Higgins","year":"2018","unstructured":"Higgins, S. P. et al. TGF-beta1\/p53 signaling in renal fibrogenesis. Cell. Signal. 43, 1\u201310 (2018).","journal-title":"Cell. Signal."},{"key":"3322_CR48","doi-asserted-by":"crossref","unstructured":"Lin, S. et al. Fibroblast growth factor 21 attenuates diabetes-induced renal fibrosis by negatively regulating TGF-beta-p53-Smad2\/3-mediated epithelial-to-mesenchymal transition via activation of AKT. Diabetes Metab. J. 44, 158\u2013172 (2019).","DOI":"10.4093\/dmj.2018.0235"},{"key":"3322_CR49","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1016\/j.cellsig.2013.07.007","volume":"25","author":"R Samarakoon","year":"2013","unstructured":"Samarakoon, R. et al. Induction of renal fibrotic genes by TGF-\u03b21 requires EGFR activation, p53 and reactive oxygen species. Cell. Signal. 25, 2198\u20132209 (2013).","journal-title":"Cell. Signal."},{"key":"3322_CR50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.21037\/atm.2020.02.12","volume":"8","author":"R Qi","year":"2020","unstructured":"Qi, R. et al. Cyclic helix B peptide ameliorates renal tubulointerstitial fibrosis induced by unilateral ureter obstruction via inhibiting NLRP3 pathway. Ann. Transl. Med. 8, 167 (2020).","journal-title":"Ann. Transl. Med."},{"key":"3322_CR51","doi-asserted-by":"publisher","first-page":"416036","DOI":"10.1155\/2012\/416036","volume":"2012","author":"J Lee","year":"2012","unstructured":"Lee, J., Rhee, M. H., Kim, E. & Cho, J. Y. BAY 11-7082 is a broad-spectrum inhibitor with anti-inflammatory activity against multiple targets. Mediators Inflamm. 2012, 416036 (2012).","journal-title":"Mediators Inflamm."},{"key":"3322_CR52","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.7150\/thno.38640","volume":"10","author":"T Wilhelmi","year":"2020","unstructured":"Wilhelmi, T. et al. Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1. Theranostics 10, 3905\u20133924 (2020).","journal-title":"Theranostics"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03322-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03322-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03322-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T21:08:29Z","timestamp":1674853709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03322-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["3322"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-03322-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study has been approved by the Ethical Committee of Zhongshan Hospital, Fudan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"44"}}